Hepagene 雅创医药

Hepagene.com

雅创医药

ABOUT HEPAGENE

Non-alcoholic Steatohepatitis (NASH)

Chronic Hepatitis B Infection (HBV)

PIPELINE

Hepagene Therapeutics, Inc, Announces Dosing of First Healthy Subject in a Phase I Study of HPG1860 for NASH

About HPG1860

About NASH

About Hepagene Therapeutics, Inc

MANAGEMENT TEAM

CONTACT US
For further information, please contact:
investor@hepagene.com
Nanjing:
No. C1-1 Treehouse Headquarter Cluster, No.73 Tanmi Road, Jiangbei New Area, Nanjing.